These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
194 related items for PubMed ID: 2745357
1. Analysis of risk factors for fatal hemorrhage during induction therapy of patients with acute promyelocytic leukemia. Ventura GJ, Hester JP, Dixon DO, Khorana S, Keating MJ. Hematol Pathol; 1989; 3(1):23-8. PubMed ID: 2745357 [Abstract] [Full Text] [Related]
2. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience]. Rolovitsh Z, Cholovitsh M, Elezovitsh I, Vidovitsh A, Radoshevitsh-Radojkovitsh N, Boshkovitsh D, Novak A, Basara N. Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239 [Abstract] [Full Text] [Related]
3. [Therapy of disseminated intravascular coagulation in acute promyelocytic leukemias. Apropos of 19 cases]. Rodríguez Gómez M, López Fernández MF, Batlle J. Sangre (Barc); 1993 Dec; 38(6):449-53. PubMed ID: 8171380 [Abstract] [Full Text] [Related]
4. Severe hemorrhagic complications during remission induction therapy for acute promyelocytic leukemia: incidence, risk factors, and influence on outcome. Yanada M, Matsushita T, Asou N, Kishimoto Y, Tsuzuki M, Maeda Y, Horikawa K, Okada M, Ohtake S, Yagasaki F, Matsumoto T, Kimura Y, Shinagawa K, Iwanaga M, Miyazaki Y, Ohno R, Naoe T. Eur J Haematol; 2007 Mar; 78(3):213-9. PubMed ID: 17241371 [Abstract] [Full Text] [Related]
5. Childhood acute promyelocytic leukemia: no benefit of all-trans-retinoic acid administered in a short-course schedule. Zubizarreta PA, Rose AB, Felice MS, Alfaro E, Delfino S, Cygler AM, Sackmann-Muriel F. Pediatr Hematol Oncol; 2000 Mar; 17(2):155-62. PubMed ID: 10734658 [Abstract] [Full Text] [Related]
6. Predictive factors of bleeding and thrombosis during induction therapy in acute promyelocytic leukemia-a single center experience in 34 patients. Dally N, Hoffman R, Haddad N, Sarig G, Rowe JM, Brenner B. Thromb Res; 2005 Mar; 116(2):109-14. PubMed ID: 15907524 [Abstract] [Full Text] [Related]
10. Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry. Lehmann S, Ravn A, Carlsson L, Antunovic P, Deneberg S, Möllgård L, Derolf AR, Stockelberg D, Tidefelt U, Wahlin A, Wennström L, Höglund M, Juliusson G. Leukemia; 2011 Jul; 25(7):1128-34. PubMed ID: 21502956 [Abstract] [Full Text] [Related]
11. [Therapy of acute promyelocytic leukemia in Czechia: results and analysis of prognostic factors]. Schwarz J, Korístek Z, Starý J, Zák P, Kozák T, Marková J, Michalová K, Dvoráková D, Mayer J, Cetkovský P. Vnitr Lek; 2008 Jul; 54(7-8):757-70. PubMed ID: 18780575 [Abstract] [Full Text] [Related]
12. Open issues on bleeding and thrombosis in acute promyelocytic leukemia. Sanz MA, Montesinos P. Thromb Res; 2010 Apr; 125 Suppl 2():S51-4. PubMed ID: 20434005 [Abstract] [Full Text] [Related]
13. A survival study and prognostic factors analysis on acute promyelocytic leukemia at a single center. Xin L, Wan-jun S, Zeng-jun L, Yao-zhong Z, Yun-tao L, Yan L, Chang-chun W, Qiao-chuan L, Ren-chi Y, Ming-zhe H, Jian-xiang W, Lu-gui Q. Leuk Res; 2007 Jun; 31(6):765-71. PubMed ID: 17007927 [Abstract] [Full Text] [Related]
16. [Long-term follow-up of treatment outcome and prognosis on 46 children with acute promyelocytic leukemia]. Xu XJ, Shi SW, Tang YM, Song H, Yang SL, Wei J, Xu WQ, Pan BH, Chen YH, Zhao FY, Shen HQ, Qian BQ, Zhang LY, Ning BT. Zhongguo Dang Dai Er Ke Za Zhi; 2007 Feb; 9(1):28-33. PubMed ID: 17306073 [Abstract] [Full Text] [Related]